ImportRefusal LogoImportRefusal

Degorts Chemical

⚠️ High Risk

FEI: 3006308082 • Ciudad De Mexico, Ciudad de Mexico • MEXICO

FEI

FEI Number

3006308082

📍

Location

Ciudad De Mexico, Ciudad de Mexico

🇲🇽

Country

MEXICO
🏢

Address

Calle Alhambra No. 310, Col. Portales Sur, Benito Juarez, Ciudad De Mexico, Ciudad de Mexico, Mexico

High Risk

FDA Import Risk Assessment

68.4
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

16
Total Refusals
2
Unique Violations
9/24/2025
Latest Refusal
11/9/2016
Earliest Refusal

Score Breakdown

Violation Severity
85.6×40%
Refusal Volume
45.6×30%
Recency
93.6×20%
Frequency
18.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7516×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

Refusal History

DateProductViolationsDivision
9/24/2025
60LDY01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/24/2025
60LDY01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/24/2025
62GDY49NAPROXEN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/17/2019
62GCL49NAPROXEN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/5/2019
60XCA17ATENOLOL (ANTI-ADRENERGIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/6/2018
62GDC49NAPROXEN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/30/2017
66VCA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/7/2017
61MCA99ANTI-CONVULSANT, N.E.C.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/18/2017
56BCB03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/1/2017
62GDA49NAPROXEN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/10/2017
62GCA49NAPROXEN (ANTI-INFLAMMATORY)
75UNAPPROVED
New Orleans District Office (NOL-DO)
2/3/2017
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/18/2017
61NCA29FLUOXETINE (ANTI-DEPRESSANT)
75UNAPPROVED
New Orleans District Office (NOL-DO)
12/9/2016
62GCA51NAPROXOL (ANTI-INFLAMMATORY)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2016
65PCB02SILDENAFIL CITRATE (REGULATOR)
75UNAPPROVED
New Orleans District Office (NOL-DO)
11/9/2016
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Degorts Chemical's FDA import refusal history?

Degorts Chemical (FEI: 3006308082) has 16 FDA import refusal record(s) in our database, spanning from 11/9/2016 to 9/24/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Degorts Chemical's FEI number is 3006308082.

What types of violations has Degorts Chemical received?

Degorts Chemical has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Degorts Chemical come from?

All FDA import refusal data for Degorts Chemical is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.